Detailed company information
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q4Released: Aug 27, 2026
Earnings Transcript for 2026 - Q3Released: May 07, 2026
Earnings Transcript for 2026 - Q2Released: Feb 05, 2026
Earnings Transcript for 2026 - Q1Released: Nov 06, 2025
Earnings Transcript for 2025 - Q4Released: Aug 28, 2025
Earnings Transcript for 2025 - Q3Released: May 10, 2025
Earnings Transcript for 2025 - Q2Released: Feb 06, 2025
Earnings Transcript for 2025 - Q1Released: Nov 08, 2024
Earnings Transcript for 2024 - Q4Released: Aug 29, 2024
Earnings Transcript for 2024 - Q3Released: May 10, 2024
Earnings Transcript for 2024 - Q2Released: Feb 08, 2024
Earnings Transcript for 2024 - Q1Released: Nov 10, 2023
Earnings Transcript for 2023 - Q4Released: Aug 31, 2023
Earnings Transcript for 2023 - Q3Released: May 06, 2023
Earnings Transcript for 2023 - Q2Released: Feb 09, 2023
Earnings Transcript for 2023 - Q1Released: Nov 13, 2022
Earnings Transcript for 2022 - Q4Released: Aug 25, 2022
Earnings Transcript for 2022 - Q3Released: May 08, 2022
Earnings Transcript for 2022 - Q2Released: Feb 10, 2022
Earnings Transcript for 2022 - Q1Released: Nov 05, 2021
Earnings Transcript for 2021 - Q4Released: Aug 26, 2021
Earnings Transcript for 2021 - Q3Released: May 09, 2021
Earnings Transcript for 2021 - Q2Released: Feb 05, 2021
Earnings Transcript for 2021 - Q1Released: Nov 05, 2020